Updated: June 11, 2021 10:46:34 pm
Taking action against black marketing of drugs used in Covid-19 treatment, the State Food and Drug Administration (FDA) has filed police complaints against 133 people across Maharashtra over the past few months. The cases pertain to illegal sale of Remedisivir, Tocilizumab and other injections.
The FDA has filed an affidavit in the Bombay High Court in response to a petition claiming that the state was not taking action against those involved in the black marketing of these drugs.
The Union government had taken control over Remdesivir distribution across the country while stopping its availability in medical stores after there was a shortage of Remedisivir injections in the state in April and May.
During this period, hospitals were asking relatives of patients to procure the injections on their own.
This had spurred black marketing of Remedisivir and Tocilizumab. The FDA was working with the state police to put a stop to such practices.
As many as 44 incidents of black marketing were registered with police with 133 people across the state booked for illegally selling the injections to needy patients. Most of the offences were for illegal selling of Remdesivir injections while two offences were registered for selling Tocilizumab injection.
According to the affidavit, the FDA has registered eight police complaints in Nagpur, four each in Mumbai, Navi Mumbai and Pune.
Most cases pertain to sale of these injections without prescriptions, non-issuance of bill, the seller not having the necessary licence or selling them at a higher price than MRP. The police has seized injections worth Rs 55 lakh, a few mobile phones, motorbikes and cars from the accused.
📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines
- The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.